Table 6.
Demographics and baseline characteristics
| Demographics and Baseline Characteristics | Value |
| Age, yr, mean±SD | 51±17 |
| Male, n (%) | 21 (67.7) |
| Cause of admission, n (%) | |
| Medical | 27 (87.1) |
| Surgical | 4 (12.9) |
| ESKD, n (%) | 1 (3.2) |
| CKD, n (%) | 7 (22.6) |
| Total AKI, n (%) | 30 (96.8) |
| ATN | 26 (83.9) |
| Cardiorenal | 3 (9.7) |
| HRS | 1 (3.2) |
| PVD, n (%) | 2 (6.5) |
| CHF, n (%) | 12 (38.7) |
| Hyperlipidemia, n, % | 9 (29.0) |
| CAD, n (%) | 5 (16.1) |
| HTN, n (%) | 11 (35.5) |
| COPD, n (%) | 5 (16.1) |
| DM, n (%) | 7 (22.6) |
| Cirrhosis, n (%) | 5 (16.1) |
| Acute liver failure, n (%) | 16 (51.6) |
| Cancer, n (%) | 4 (12.9) |
| AST (U/L), median (IQR) | 822 (122–2950) |
| ALT (U/L), median (IQR) | 352 (41–2238) |
| Total bilirubin (mg/dl), median (IQR) | 2.7 (1.0–5.1) |
| INR (U), median (IQR) | 2 (1.5–2.6) |
| Lactate (mmol/L), median (IQR) | 5 (3.2–10.7) |
| Albumin (g/dl), median (IQR) | 2.7 (2.4–2.9) |
ATN, acute tubular necrosis; HRS, hepatorenal syndrome; PVD, peripheral vascular disease; CHF, congestive heart failure; CAD, coronary artery disease; HTN, hypertension; COPD, chronic obstructive pulmonary disease; DM, diabetes; AST, aspartate aminotransferase; IQR, interquartile range; ALT, alanine aminotransferase; INR, international normalized ratio.